Alkermes plc

NASDAQ:ALKS  
22.23
-0.01 (-0.04%)
Products

FDA Accepts Alkermes' Resubmission Of New Drug Application For ALKS 3831

Published: 12/29/2020 12:19 GMT
Alkermes plc (ALKS) - FDA Accepts Alkermes' Resubmission of New Drug Application for Alks 3831.
Alkermes Plc - FDA Sets PDUFA Target Action Date of June 1, 2021.